scispace - formally typeset
L

Li Yang

Researcher at Sichuan University

Publications -  371
Citations -  6789

Li Yang is an academic researcher from Sichuan University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 35, co-authored 295 publications receiving 4474 citations.

Papers
More filters
Journal ArticleDOI

Discovery of pyrazolo[1,5-a]pyrimidine-3-carbonitrile derivatives as a new class of histone lysine demethylase 4D (KDM4D) inhibitors

TL;DR: Overall, compound 10r could be taken as a good lead compound for further studies and is the most potent one with an IC50 value of 0.41±0.03μM against KDM4D.
Journal ArticleDOI

Microenvironment-responsive multifunctional hydrogels with spatiotemporal sequential release of tailored recombinant human collagen type III for the rapid repair of infected chronic diabetic wounds.

TL;DR: Wang et al. as discussed by the authors presented a tailored recombinant human collagen type III (rhCol III) and constructed a multifunctional microenvironment-responsive hydrogel carrier based on multifunctionAL antibacterial nanoparticles (PDA@Ag NPs).
Journal ArticleDOI

A thrombin-triggered self-regulating anticoagulant strategy combined with anti-inflammatory capacity for blood-contacting implants

TL;DR: It was demonstrated that the coating worked as a precise strategy to resist coagulation and inflammation, escorted reendothelialization on the cardiovascular devices, and provided a new perspective for designing endothelium-like functional coatings.
Journal ArticleDOI

Sustained and targeted delivery of siRNA/DP7-C nanoparticles from injectable thermosensitive hydrogel for hepatocellular carcinoma therapy

TL;DR: Wang et al. as discussed by the authors showed that Pin1 siRNA is an efficient method for the treatment of hepatocellular carcinoma cells and provides a sustainable and effective drug delivery system for the suppression of liver cancer.
Journal ArticleDOI

The synthesis, structure-toxicity relationship of cisplatin derivatives for the mechanism research of cisplatin-induced nephrotoxicity.

TL;DR: The potency of biotin-pyridine conjugated derivative 3 met the requirement for target identification, and the preliminary chemical proteomics results suggested that it is a promising tool for further target identification of cisplatin-induced nephrotoxicity.